• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阳离子脂质体介导的呼肠孤病毒递送增强了呼肠孤病毒在耐药肿瘤细胞中杀伤肿瘤细胞的效率。

Cationic liposome-mediated delivery of reovirus enhances the tumor cell-killing efficiencies of reovirus in reovirus-resistant tumor cells.

作者信息

Sakurai Fuminori, Inoue Shunsuke, Kaminade Tadataka, Hotani Takuma, Katayama Yuki, Hosoyamada Eri, Terasawa Yuichi, Tachibana Masashi, Mizuguchi Hiroyuki

机构信息

Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, Japan; Laboratory of Regulatory Sciences for Oligonucleotide Therapeutics, Clinical Drug Development Unit, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.

Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, Japan.

出版信息

Int J Pharm. 2017 May 30;524(1-2):238-247. doi: 10.1016/j.ijpharm.2017.04.006. Epub 2017 Apr 4.

DOI:10.1016/j.ijpharm.2017.04.006
PMID:28389364
Abstract

Reovirus induces tumor cell death efficiently and specifically, and thus is currently undergoing clinical testing as an anticancer agent. In the intracellular trafficking of reovirus, proteolytic disassembly of reovirus capsid-proteins and subsequent penetration of viral particles into the cytosol are crucial steps. Cathepsins B and L are largely responsible for the proteolytic disassembly of reovirus. Reovirus efficiently lyses tumor cells exhibiting relatively high activities of cathepsins B and L, while tumor cells with low activities of cathepsins B and L are often refractory to reovirus, probably due to inefficient endo/lysosomal escape. In this study, in order to enhance the tumor cell-killing efficiencies of reovirus by promoting endo/lysosomal escape, especially in reovirus-resistant tumor cells, reovirus was complexed with a cationic liposome transfection reagent. Reovirus alone and reovirus-cationic liposome complex (reoplex) exhibited similar levels of tumor cell-killing efficiencies in reovirus-susceptible tumor cells, while reoplex mediated more than 30% higher levels of tumor cell-killing activities in reovirus-resistant tumor cells than reovirus alone. Reoplex-mediated tumor cell death was efficiently induced in the tumor cells pretreated with cathepsin inhibitors. The mRNA levels of interferon (IFN)-β and apoptotic genes were significantly elevated following reoplex treatment. These results suggest that cationic liposomes efficiently promoted delivery of reovirus to the cytosol, leading to induction of apoptosis.

摘要

呼肠孤病毒能高效且特异性地诱导肿瘤细胞死亡,因此目前正作为一种抗癌药物进行临床试验。在呼肠孤病毒的细胞内运输过程中,病毒衣壳蛋白的蛋白水解性解离以及随后病毒颗粒进入细胞质是关键步骤。组织蛋白酶B和L在很大程度上负责呼肠孤病毒的蛋白水解性解离。呼肠孤病毒能有效裂解组织蛋白酶B和L活性相对较高的肿瘤细胞,而组织蛋白酶B和L活性较低的肿瘤细胞通常对呼肠孤病毒具有抗性,这可能是由于内吞/溶酶体逃逸效率低下所致。在本研究中,为了通过促进内吞/溶酶体逃逸来提高呼肠孤病毒对肿瘤细胞的杀伤效率,尤其是在对呼肠孤病毒耐药的肿瘤细胞中,将呼肠孤病毒与阳离子脂质体转染试剂复合。单独的呼肠孤病毒和呼肠孤病毒-阳离子脂质体复合物(复配物)在对呼肠孤病毒敏感的肿瘤细胞中表现出相似水平的肿瘤细胞杀伤效率,而在对呼肠孤病毒耐药的肿瘤细胞中,复配物介导的肿瘤细胞杀伤活性比单独的呼肠孤病毒高30%以上。在用组织蛋白酶抑制剂预处理的肿瘤细胞中,复配物介导的肿瘤细胞死亡被有效诱导。复配物处理后,干扰素(IFN)-β和凋亡基因的mRNA水平显著升高。这些结果表明,阳离子脂质体有效地促进了呼肠孤病毒向细胞质的递送,从而导致凋亡的诱导。

相似文献

1
Cationic liposome-mediated delivery of reovirus enhances the tumor cell-killing efficiencies of reovirus in reovirus-resistant tumor cells.阳离子脂质体介导的呼肠孤病毒递送增强了呼肠孤病毒在耐药肿瘤细胞中杀伤肿瘤细胞的效率。
Int J Pharm. 2017 May 30;524(1-2):238-247. doi: 10.1016/j.ijpharm.2017.04.006. Epub 2017 Apr 4.
2
Proteolytic disassembly is a critical determinant for reovirus oncolysis.蛋白水解拆解是呼肠孤病毒溶瘤作用的关键决定因素。
Mol Ther. 2007 Aug;15(8):1512-21. doi: 10.1038/sj.mt.6300207. Epub 2007 May 22.
3
Proteolytic disassembly of viral outer capsid proteins is crucial for reovirus-mediated type-I interferon induction in both reovirus-susceptible and reovirus-refractory tumor cells.病毒外衣壳蛋白的蛋白水解拆卸对于呼肠孤病毒介导的I型干扰素诱导在呼肠孤病毒易感和呼肠孤病毒难治性肿瘤细胞中都至关重要。
Biomed Res Int. 2015;2015:468457. doi: 10.1155/2015/468457. Epub 2015 Mar 19.
4
Activity levels of cathepsins B and L in tumor cells are a biomarker for efficacy of reovirus-mediated tumor cell killing.组织蛋白酶 B 和 L 在肿瘤细胞中的活性水平是反映呼肠孤病毒介导的肿瘤细胞杀伤效果的生物标志物。
Cancer Gene Ther. 2015 Mar;22(4):188-97. doi: 10.1038/cgt.2015.4. Epub 2015 Jan 30.
5
Small extracellular vesicles carrying reovirus, tumor antigens, interferon-β, and damage-associated molecular patterns for efficient tumor treatment.携带呼肠孤病毒、肿瘤抗原、干扰素-β和损伤相关分子模式的小细胞外囊泡用于有效的肿瘤治疗。
J Control Release. 2024 Oct;374:89-102. doi: 10.1016/j.jconrel.2024.07.079. Epub 2024 Aug 10.
6
Reovirus double-stranded RNA genomes and polyI:C induce down-regulation of hypoxia-inducible factor 1α.呼肠孤病毒双链RNA基因组和聚肌胞苷酸诱导缺氧诱导因子1α下调。
Biochem Biophys Res Commun. 2015 May 15;460(4):1041-6. doi: 10.1016/j.bbrc.2015.03.147. Epub 2015 Apr 2.
7
Mutant cells selected during persistent reovirus infection do not express mature cathepsin L and do not support reovirus disassembly.在持续的呼肠孤病毒感染过程中选择的突变细胞不表达成熟的组织蛋白酶L,也不支持呼肠孤病毒的解体。
J Virol. 1999 Nov;73(11):9532-43. doi: 10.1128/JVI.73.11.9532-9543.1999.
8
Cationic liposomes overcome neutralizing antibodies and enhance reovirus efficacy in ovarian cancer.阳离子脂质体克服中和抗体,提高卵巢癌中呼肠孤病毒的疗效。
Virology. 2024 Oct;598:110196. doi: 10.1016/j.virol.2024.110196. Epub 2024 Jul 31.
9
Cathepsin L and cathepsin B mediate reovirus disassembly in murine fibroblast cells.组织蛋白酶L和组织蛋白酶B介导呼肠孤病毒在小鼠成纤维细胞中的解体。
J Biol Chem. 2002 Jul 5;277(27):24609-17. doi: 10.1074/jbc.M201107200. Epub 2002 May 1.
10
Genetic and pharmacologic alteration of cathepsin expression influences reovirus pathogenesis.组织蛋白酶表达的基因和药理学改变影响呼肠孤病毒的发病机制。
J Virol. 2009 Oct;83(19):9630-40. doi: 10.1128/JVI.01095-09. Epub 2009 Jul 29.

引用本文的文献

1
Human Melanoma and Glioblastoma Cells Express Cathepsins Supporting Reovirus Moscow Strain Infection.人类黑色素瘤细胞和胶质母细胞瘤细胞表达组织蛋白酶,支持呼肠孤病毒莫斯科株感染。
Viruses. 2024 Dec 19;16(12):1944. doi: 10.3390/v16121944.
2
Progress in oncolytic viruses modified with nanomaterials for intravenous application.纳米材料修饰的溶瘤病毒在静脉给药方面的研究进展。
Cancer Biol Med. 2023 Nov 24;20(11):830-55. doi: 10.20892/j.issn.2095-3941.2023.0275.
3
Protease-triggered bioresponsive drug delivery for the targeted theranostics of malignancy.
蛋白酶触发的生物响应性药物递送用于恶性肿瘤的靶向治疗诊断。
Acta Pharm Sin B. 2021 Aug;11(8):2220-2242. doi: 10.1016/j.apsb.2021.01.017. Epub 2021 Jan 24.
4
Mesenchymal stem cell carriers enhance anti-tumor efficacy of oncolytic virotherapy.间充质干细胞载体增强溶瘤病毒疗法的抗肿瘤疗效。
Oncol Lett. 2021 Apr;21(4):238. doi: 10.3892/ol.2021.12499. Epub 2021 Jan 28.
5
Oncolytic Virotherapy in Solid Tumors: The Challenges and Achievements.实体瘤中的溶瘤病毒疗法:挑战与成就
Cancers (Basel). 2021 Feb 3;13(4):588. doi: 10.3390/cancers13040588.
6
Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors.试验观察:血液系统肿瘤和实体瘤的溶瘤病毒免疫疗法
Oncoimmunology. 2018 Aug 27;7(12):e1503032. doi: 10.1080/2162402X.2018.1503032. eCollection 2018.
7
Going (Reo)Viral: Factors Promoting Successful Reoviral Oncolytic Infection.走向(Reo)病毒:促进成功的 Reo 病毒溶瘤感染的因素。
Viruses. 2018 Aug 11;10(8):421. doi: 10.3390/v10080421.